50 related articles for article (PubMed ID: 20336365)
1. High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer.
Met O; Balslev E; Flyger H; Svane IM
Breast Cancer Res Treat; 2011 Jan; 125(2):395-406. PubMed ID: 20336365
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.
Schuetz F; Ehlert K; Ge Y; Schneeweiss A; Rom J; Inzkirweli N; Sohn C; Schirrmacher V; Beckhove P
Cancer Immunol Immunother; 2009 Jun; 58(6):887-900. PubMed ID: 18998129
[TBL] [Abstract][Full Text] [Related]
3. Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients.
Domschke C; Schuetz F; Sommerfeldt N; Rom J; Scharf A; Sohn C; Schneeweiss A; Beckhove P
Cancer Immunol Immunother; 2010 Mar; 59(3):479-86. PubMed ID: 19957084
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neck.
Andrade Filho PA; Ito D; Deleo AB; Ferris RL
Cancer Immunol Immunother; 2010 Oct; 59(10):1561-8. PubMed ID: 20577877
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.
Svane IM; Pedersen AE; Johansen JS; Johnsen HE; Nielsen D; Kamby C; Ottesen S; Balslev E; Gaarsdal E; Nikolajsen K; Claesson MH
Cancer Immunol Immunother; 2007 Sep; 56(9):1485-99. PubMed ID: 17285289
[TBL] [Abstract][Full Text] [Related]
6. Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients.
Domschke C; Schuetz F; Ge Y; Rom J; Zorn M; Sinn HP; Marmé F; Schott S; Heil J; Scharf A; Sohn C; Schneeweiss A; Beckhove P
Cancer Immunol Immunother; 2011 Mar; 60(3):401-11. PubMed ID: 21161218
[TBL] [Abstract][Full Text] [Related]
7. Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.
Song B; Yang P; Zhang S
Cancer Commun (Lond); 2024 Mar; 44(3):297-360. PubMed ID: 38311377
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in targeting the "undruggable" proteins: from drug discovery to clinical trials.
Xie X; Yu T; Li X; Zhang N; Foster LJ; Peng C; Huang W; He G
Signal Transduct Target Ther; 2023 Sep; 8(1):335. PubMed ID: 37669923
[TBL] [Abstract][Full Text] [Related]
9. mRNA vaccination in breast cancer: current progress and future direction.
Jiang XT; Liu Q
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9435-9450. PubMed ID: 37100972
[TBL] [Abstract][Full Text] [Related]
10. A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Kjeldsen JW; Lorentzen CL; Martinenaite E; Ellebaek E; Donia M; Holmstroem RB; Klausen TW; Madsen CO; Ahmed SM; Weis-Banke SE; Holmström MO; Hendel HW; Ehrnrooth E; Zocca MB; Pedersen AW; Andersen MH; Svane IM
Nat Med; 2021 Dec; 27(12):2212-2223. PubMed ID: 34887574
[TBL] [Abstract][Full Text] [Related]
11. Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens.
Holmen Olofsson G; Idorn M; Carnaz Simões AM; Aehnlich P; Skadborg SK; Noessner E; Debets R; Moser B; Met Ö; Thor Straten P
Front Immunol; 2021; 12():645131. PubMed ID: 34149689
[TBL] [Abstract][Full Text] [Related]
12. mRNA vaccine: a potential therapeutic strategy.
Wang Y; Zhang Z; Luo J; Han X; Wei Y; Wei X
Mol Cancer; 2021 Feb; 20(1):33. PubMed ID: 33593376
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T cells isolated from healthy donors and cancer patients kill TGFβ-expressing cancer cells in a TGFβ-dependent manner.
Holmström MO; Mortensen REJ; Pavlidis AM; Martinenaite E; Weis-Banke SE; Aaboe-Jørgensen M; Bendtsen SK; Met Ö; Pedersen AW; Donia M; Svane IM; Andersen MH
Cell Mol Immunol; 2021 Feb; 18(2):415-426. PubMed ID: 33408343
[TBL] [Abstract][Full Text] [Related]
14. The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.
Weis-Banke SE; Hübbe ML; Holmström MO; Jørgensen MA; Bendtsen SK; Martinenaite E; Carretta M; Svane IM; Ødum N; Pedersen AW; Met Ö; Madsen DH; Andersen MH
Oncoimmunology; 2020 Jun; 9(1):1771142. PubMed ID: 32923127
[TBL] [Abstract][Full Text] [Related]
15. Frequent adaptive immune responses against arginase-1.
Martinenaite E; Mortensen REJ; Hansen M; Orebo Holmström M; Munir Ahmad S; Grønne Dahlager Jørgensen N; Met Ö; Donia M; Svane IM; Andersen MH
Oncoimmunology; 2018; 7(3):e1404215. PubMed ID: 29399404
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy.
Ahmad SM; Martinenaite E; Holmström M; Jørgensen MA; Met Ö; Nastasi C; Klausen U; Donia M; Pedersen LM; Munksgaard L; Ødum N; Woetmann A; Svane IM; Andersen MH
Oncoimmunology; 2018; 7(2):e1390641. PubMed ID: 29308318
[TBL] [Abstract][Full Text] [Related]
17. The mutational status of p53 can influence its recognition by human T-cells.
Shamalov K; Levy SN; Horovitz-Fried M; Cohen CJ
Oncoimmunology; 2017; 6(4):e1285990. PubMed ID: 28507791
[TBL] [Abstract][Full Text] [Related]
18. New Immunotherapy Strategies in Breast Cancer.
Yu LY; Tang J; Zhang CM; Zeng WJ; Yan H; Li MP; Chen XP
Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28085094
[TBL] [Abstract][Full Text] [Related]
19. CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment.
Martinenaite E; Munir Ahmad S; Hansen M; Met Ö; Westergaard MW; Larsen SK; Klausen TW; Donia M; Svane IM; Andersen MH
Oncoimmunology; 2016; 5(11):e1238541. PubMed ID: 27999757
[TBL] [Abstract][Full Text] [Related]
20. The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.
Holmström MO; Hjortsø MD; Ahmad SM; Met Ö; Martinenaite E; Riley C; Straten P; Svane IM; Hasselbalch HC; Andersen MH
Leukemia; 2017 Feb; 31(2):495-498. PubMed ID: 27761006
[No Abstract] [Full Text] [Related]
[Next] [New Search]
